CVS.NE
CVS Health Corporation
Cboe CACADEQUITY
DELAYED
Last price
22.24
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
22.24
Day high
22.31
Day low
22.10
Volume
2.00K
Market cap
—
P/E (TTM)
—
52W range
11.20 – 22.31
Free account
3 more panels on CVS.NE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $402.07B | $372.81B | $357.78B | $322.47B | +7.8% |
| Operating revenue | $402.07B | $372.81B | $357.78B | $322.47B | +7.8% |
| Cost of revenue | $346.70B | $321.41B | $303.35B | $267.96B | +7.9% |
| Gross profit | $55.36B | $51.40B | $54.43B | $54.50B | +7.7% |
| Total operating expense | $44.98B | $41.71B | $39.83B | $38.21B | +7.8% |
| Operating income | $10.38B | $9.70B | $14.60B | $16.29B | +7.1% |
| Net interest income | -$3.12B | -$2.96B | -$2.66B | -$2.29B | -5.4% |
| Pre-tax income | $2.14B | $6.15B | $11.17B | $5.84B | -65.3% |
| Tax provision | $408.00M | $1.56B | $2.81B | $1.51B | -73.9% |
| Net income | $1.77B | $4.61B | $8.34B | $4.31B | -61.7% |
| Net income to common | $1.77B | $4.61B | $8.34B | $4.31B | -61.7% |
| Basic EPS | 0.25 | 0.67 | 1.18 | 0.60 | -61.9% |
| Diluted EPS | 0.25 | 0.67 | 1.18 | 0.59 | -62.0% |
| EBIT | $5.25B | $9.11B | $13.83B | $8.12B | -42.3% |
| EBITDA | $9.86B | $13.70B | $18.20B | $12.35B | -28.0% |
| Basic shares | 6.96B | 6.91B | 7.06B | 7.21B | +0.6% |
| Diluted shares | 6.98B | 6.93B | 7.09B | 7.27B | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $8.45B | $8.59B | $8.20B | $12.95B | -1.5% |
| Cash & short-term investments | $10.60B | $10.99B | $11.46B | $15.72B | -3.6% |
| Accounts receivable | $16.32B | $14.61B | $15.62B | $11.66B | +11.7% |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | +6.3% |
| Total current assets | $74.71B | $68.64B | $67.86B | $65.63B | +8.8% |
| Property, plant & equipment | $28.06B | $28.94B | $30.43B | $30.75B | -3.0% |
| Goodwill & intangibles | $110.99B | $118.59B | $120.51B | $102.95B | -6.4% |
| Total assets | $253.54B | $253.22B | $249.73B | $228.28B | +0.1% |
| Total current liabilities | $88.69B | $84.61B | $79.19B | $69.42B | +4.8% |
| Current debt | $4.07B | $5.74B | $2.97B | $1.78B | -29.2% |
| Long-term debt | $60.50B | $60.53B | $58.64B | $50.48B | -0.0% |
| Total debt | $79.95B | $82.92B | $79.39B | $70.73B | -3.6% |
| Total liabilities | $178.16B | $177.49B | $173.09B | $156.51B | +0.4% |
| Retained earnings | $61.20B | $62.84B | $61.60B | $56.40B | -2.6% |
| Shareholder equity | $75.21B | $75.56B | $76.46B | $71.47B | -0.5% |
| Working capital | -$13.98B | -$15.96B | -$11.33B | -$3.79B | +12.4% |
| Net tangible assets | -$35.77B | -$43.03B | -$44.05B | -$31.48B | +16.9% |
| Shares issued | 1.79B | 1.78B | 1.77B | 1.76B | +0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.73B | $4.59B | $8.37B | $4.33B | -62.3% |
| Depreciation & amortisation | $4.61B | $4.60B | $4.37B | $4.22B | +0.2% |
| Stock-based compensation | $535.00M | $540.00M | $588.00M | $447.00M | -0.9% |
| Change in working capital | -$1.47B | $109.00M | $15.00M | $6.82B | -1,452.3% |
| Operating cash flow | $10.64B | $9.11B | $13.43B | $16.18B | +16.8% |
| Capital expenditure | -$2.83B | -$2.78B | -$3.03B | -$2.73B | -1.8% |
| Investing cash flow | -$5.87B | -$7.61B | -$20.89B | -$5.05B | +22.9% |
| Share buybacks | $0 | -$3.02B | -$2.01B | -$3.50B | +100.0% |
| Dividends paid | -$3.40B | -$3.37B | -$3.13B | -$2.91B | -0.7% |
| Financing cash flow | -$4.94B | -$1.14B | $2.68B | -$10.52B | -335.2% |
| Free cash flow | $7.81B | $6.33B | $10.39B | $13.45B | +23.4% |
| End cash position | $8.71B | $8.88B | $8.53B | $13.30B | -1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | — | +5.6% |
| Operating revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | — | +5.6% |
| Cost of revenue | $90.35B | $84.80B | $92.13B | $89.06B | $85.32B | — | +6.5% |
| Gross profit | $15.75B | $15.62B | $13.57B | $13.81B | $13.59B | — | +0.8% |
| Total operating expense | $11.05B | $10.94B | $11.46B | $11.29B | $11.21B | — | +0.9% |
| Operating income | $4.70B | $4.68B | $2.11B | $2.52B | $2.38B | — | +0.5% |
| Net interest income | -$757.00M | -$774.00M | -$787.00M | -$784.00M | -$763.00M | — | +2.2% |
| Pre-tax income | $3.98B | $3.94B | $1.35B | -$3.48B | $1.65B | — | +1.0% |
| Tax provision | $982.00M | $981.00M | -$1.57B | $508.00M | $634.00M | — | +0.1% |
| Net income | $2.98B | $2.94B | $2.94B | -$3.98B | $1.02B | — | +1.2% |
| Net income to common | $2.98B | $2.94B | $2.94B | -$3.98B | $1.02B | — | +1.2% |
| Basic EPS | 0.42 | 0.42 | 0.42 | — | 0.15 | 0.26 | +0.9% |
| Diluted EPS | 0.42 | 0.42 | 0.42 | — | 0.15 | 0.26 | +0.4% |
| EBIT | $4.73B | $4.71B | $2.14B | -$2.70B | $2.41B | — | +0.5% |
| EBITDA | $5.86B | $5.83B | $3.29B | -$1.56B | $3.58B | — | +0.6% |
| Basic shares | 7.02B | 6.99B | 6.98B | — | 6.95B | 6.93B | +0.5% |
| Diluted shares | 7.07B | 7.02B | 7.01B | — | 6.98B | 6.94B | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | +18.7% |
| Cash & short-term investments | $13.96B | $11.80B | $10.60B | $11.23B | $14.17B | +18.3% |
| Accounts receivable | $19.38B | $20.14B | $16.32B | $16.10B | $16.35B | -3.8% |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | -0.8% |
| Total current assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | +0.7% |
| Property, plant & equipment | $27.62B | $27.78B | $28.06B | $28.11B | $28.34B | -0.6% |
| Goodwill & intangibles | $110.12B | $110.55B | $110.99B | $111.46B | $117.43B | -0.4% |
| Total assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | +0.3% |
| Total current liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | +0.7% |
| Current debt | $1.96B | $2.58B | $4.07B | $5.33B | $9.20B | -24.1% |
| Long-term debt | $59.45B | $60.53B | $60.50B | $60.51B | $57.29B | -1.8% |
| Total debt | $76.31B | $78.34B | $79.95B | $81.75B | $82.72B | -2.6% |
| Total liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | -0.8% |
| Retained earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | +3.3% |
| Shareholder equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | +2.9% |
| Working capital | -$11.70B | -$11.59B | -$13.98B | -$15.59B | -$18.51B | -0.9% |
| Net tangible assets | -$30.42B | -$33.09B | -$35.77B | -$38.53B | -$40.05B | +8.1% |
| Shares issued | 1.28B | 1.79B | 1.79B | 1.79B | 1.78B | -28.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $3.00B | $2.96B | $2.92B | -$3.99B | $1.01B | — | +1.3% |
| Depreciation & amortisation | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | — | +1.0% |
| Stock-based compensation | $176.00M | $266.00M | $135.00M | $138.00M | $136.00M | — | -33.8% |
| Change in working capital | $2.20B | $2.00M | -$1.02B | -$1.57B | -$309.00M | — | +109,800.0% |
| Operating cash flow | $6.34B | $4.25B | $3.39B | $796.00M | $1.90B | — | +49.3% |
| Capital expenditure | -$691.00M | -$849.00M | -$784.00M | -$698.00M | -$607.00M | — | +18.6% |
| Investing cash flow | -$1.88B | -$874.00M | -$2.00B | -$2.09B | -$1.02B | — | -115.6% |
| Share buybacks | — | — | $0 | $0 | $0 | $0 | — |
| Dividends paid | -$878.00M | -$847.00M | -$845.00M | -$846.00M | -$866.00M | — | -3.7% |
| Financing cash flow | -$2.69B | -$2.32B | -$2.03B | -$1.38B | $806.00M | — | -16.2% |
| Free cash flow | $5.65B | $3.40B | $2.61B | $98.00M | $1.29B | — | +66.3% |
| End cash position | $11.54B | $9.77B | $8.71B | $9.35B | $12.03B | — | +18.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
—
5Y monthly, from filing
Headlines
Marvell's Next AI Opportunity Could Be Worth Billions
GuruFocus.com · 4m ago
Tesla's Biggest Robotaxi Test Arrives Sept. 3
GuruFocus.com · 5m ago
The Retirement Nobody Budgets For. What the Last Ten Years of Care Actually Cost
24/7 Wall St. · 9m ago
Energys Reports Acquisition of UK Delivery, Fulfilment Partners
MT Newswires · 9m ago
Coinbase Global Selects Chainlink to Provide Pricing Data for Tokenized Stocks
MT Newswires · 9m ago
Sector Update: Tech Stocks Fall Monday Afternoon
MT Newswires · 9m ago
ExxonMobil vs. Chevron: We Compared 10 Years of Dividend Growth And Here’s the Winner
24/7 Wall St. · 9m ago
Ancora Reaffirms Offer to Acquire H.B. Fuller’s BAS Segment
Business Wire · 9m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.